Alia Shoaib is a freelance news reporter for Newsweek based between London, UK and Abuja, Nigeria. She primarily reports on U.S. politics and current affairs. Alia joined Newsweek in 2024 from ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

Tom Westerholm is a Life & Trends Reporter for Newsweek based in Michigan. His work is focused on reporting on trending topics. Tom joined Newsweek in 2023 from Boston.com and previously worked at ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

Nasal sprays can treat congestion and other symptoms of seasonal allergies or a cold. They work by delivering a fine mist of medication into your nostrils. Since the lining of your nose is rich with ...